SCHEMBL2767279

SCHEMBL2767279

COCOc1ccc(N2CCN(CC(=O)c3ccccc3)CC2)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTR1A P08908 2/20 0.46
ENPP2 Q13822 1/20 0.45
TSHR P16473 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44
KDR P35968 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2767454 0.79 POLB (0.57) POLBMEN1KMT2AALDH1A1MAPT
SCHEMBL2767494 0.79 SIGMAR1 (0.56) MAPTHTR1ANPSR1
SCHEMBL19851992 0.75 TSHR (0.64) POLBMEN1KMT2AALDH1A1MAPT
SCHEMBL27638464 0.75 MAPT (0.41) MEN1KMT2AALDH1A1MAPTENPP2
SCHEMBL27638449 0.73 MAPT (0.42) MEN1KMT2AALDH1A1MAPTCYP3A4
SCHEMBL351380 0.73 POLB (0.74) POLBMEN1KMT2AALDH1A1MAPT
SCHEMBL16742541 0.73 INSR (0.46) MEN1KMT2AALDH1A1MAPTTSHR
SCHEMBL2767154 0.73 ADRB1 (0.56) ALDH1A1MAPTCYP1A2CYP3A4CYP2D6
SCHEMBL3137445 0.72 MAPT (0.53) MEN1KMT2AALDH1A1MAPTCYP3A4
SCHEMBL4875267 0.70 ALDH1A1 (0.79) POLBMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA POLB 1363/4885MEN1 3596/4885KMT2A 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.